Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 106UNKNOWN 4NIH 3OTHER_GOV 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3CNS 1

Conditions

Breast Neoplasms 3Brain Neoplasms 1

Interventions

Paclitaxel 20Capecitabine 18S 1 (combination) 17Cisplatin 15Oxaliplatin 11Radiotherapy, Intensity-Modulated 9apatinib 8Epirubicin 8Docetaxel 8Carboplatin 8Radiotherapy 7Irinotecan 7titanium silicide 6sintilimab 6pyrotinib 6nimotuzumab 6anlotinib 6Drug Therapy 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6nedaplatin 5camrelizumab 5Temozolomide 5Etoposide 5Bevacizumab 5nabiximols 4Vinorelbine 4Trastuzumab 4Radiation Dose Hypofractionation 4Pemetrexed 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × Radiation Dose Hypofractionation × Clear all
NCT05045287 2021-09-16

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

ChineseAMS

Phase NA Unknown
57 enrolled
Breast

Breast Neoplasms

NCT03778541 2019-07-23

HFSRT With Concurrent TMZ for Large BMs

ChineseAMS

Phase 3 Unknown
224 enrolled
CNS

Brain Neoplasms

NCT00793962 2018-10-11

A Phase â…¢ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

ChineseAMS

Phase 3 Completed
810 enrolled
Breast

Breast Neoplasms

NCT02460744 2015-06-02

2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer

PIMERIndia

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡